Skip to main content
Erschienen in: World Journal of Urology 5/2003

01.11.2003 | Topic Paper

Androgens and male fertility

verfasst von: G. R. Dohle, M. Smit, R. F. A. Weber

Erschienen in: World Journal of Urology | Ausgabe 5/2003

Einloggen, um Zugang zu erhalten

Abstract

Androgens play a crucial role in the development of male reproductive organs such as the epididymis, vas deferens, seminal vesicle, prostate and the penis. Furthermore, androgens are needed for puberty, male fertility and male sexual function. High levels of intratesticular testosterone, secreted by the leydig cells, are necessary for spermatogenesis. Intratesticular testosterone is mainly bound to androgen binding protein and secreted into the seminiferous tubules. Inside the sertoli cells, testosterone is selectively bound to the androgen receptor and activation of the receptor will result in initiation and maintenance of the spermatogenic process and inhibition of germ cell apoptosis. The androgen receptor is found in all male reproductive organs and can be stimulated by either testosterone or its more potential metabolite dihydrotestosterone. Severe defects of the androgen receptor may result in abnormal male sexual development. More subtle modulations can be a potential cause of male infertility. Treatment of an infertile man with testosterone does improve spermatogenesis, since exogenous administrated testosterone and its metabolite estrogen will suppress both GnRH production by the hypothalamus and Luteinising hormone production by the pituitary gland and subsequently suppress testicular testosterone production. Also, high levels of testosterone are needed inside the testis and this can never be accomplished by oral or parenteral administration of androgens. Suppression of testosterone production by the leydig cells will result in a deficient spermatogenesis, as can be seen in men taking anabolic-androgenic steroids. Suppression of spermatogenesis by testosterone administration is also the basis for the development of a male contraceptive. During cytotoxic treatment or irradiation suppression of intratesticular testosterone production cells may prevent irreversible damage to the spermotogonial stem cells.
Literatur
1.
Zurück zum Zitat Bentvelsen FM, McPhaul MJ, Wilson JD, George FW (1994) The androgen receptor of the urogenital tract of the fetal rat is regulated by androgen. Mol Cell Endocrinol 105(1):21–26CrossRefPubMed Bentvelsen FM, McPhaul MJ, Wilson JD, George FW (1994) The androgen receptor of the urogenital tract of the fetal rat is regulated by androgen. Mol Cell Endocrinol 105(1):21–26CrossRefPubMed
2.
Zurück zum Zitat Brinkmann AO, Jenster G, Ris-Stalpers C, van der Korput JA, Bruggenwirth HT, Boehmer AL, Trapman J (1995) Androgen receptor mutations. J Steroid Biochem Mol Biol 53(1–6):443–448 Brinkmann AO, Jenster G, Ris-Stalpers C, van der Korput JA, Bruggenwirth HT, Boehmer AL, Trapman J (1995) Androgen receptor mutations. J Steroid Biochem Mol Biol 53(1–6):443–448
3.
Zurück zum Zitat Cooper TG (1996) Epididymis and sperm function. Andrologia 28[Suppl 1]: 57–59 Cooper TG (1996) Epididymis and sperm function. Andrologia 28[Suppl 1]: 57–59
4.
Zurück zum Zitat De Kretser DM, Burger HG, Fortune D, Hudson B, Long AR, Paulsen CA, Taft HP (1972) Hormonal, histological and chromosomal studies in adult males with testicular disorders. J Clin Endocrinol Metab 35:392–401PubMed De Kretser DM, Burger HG, Fortune D, Hudson B, Long AR, Paulsen CA, Taft HP (1972) Hormonal, histological and chromosomal studies in adult males with testicular disorders. J Clin Endocrinol Metab 35:392–401PubMed
5.
Zurück zum Zitat Giwercman YL, Xu C, Arver S, Pousette A, Reneland R (1998) No association between the androgen receptor gene CAG repeat and impaired sperm production in Swedish men. Clin Genet 54:435–436PubMed Giwercman YL, Xu C, Arver S, Pousette A, Reneland R (1998) No association between the androgen receptor gene CAG repeat and impaired sperm production in Swedish men. Clin Genet 54:435–436PubMed
6.
Zurück zum Zitat Handelsman DJ (1994) Testicular dysfunction in systemic disease. Endocrinol Metab Clin North Am 23:839–856PubMed Handelsman DJ (1994) Testicular dysfunction in systemic disease. Endocrinol Metab Clin North Am 23:839–856PubMed
7.
Zurück zum Zitat Johnsen SG (1978) Maintenance of spermatogenesis induced by HMG treatment by means of continuous HCG treatment in hypogonadotrophic men. Acta Endocrinol 89(4):763–769PubMed Johnsen SG (1978) Maintenance of spermatogenesis induced by HMG treatment by means of continuous HCG treatment in hypogonadotrophic men. Acta Endocrinol 89(4):763–769PubMed
8.
Zurück zum Zitat Kreuser ED, Klingmuller D, Thiel E (1993) The role of LHRH-analogues in protecting gonadal functions during chemotherapy and irradiation. Eur Urol 23(1):157–163PubMed Kreuser ED, Klingmuller D, Thiel E (1993) The role of LHRH-analogues in protecting gonadal functions during chemotherapy and irradiation. Eur Urol 23(1):157–163PubMed
9.
Zurück zum Zitat La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 4;352:77–79 La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 4;352:77–79
10.
Zurück zum Zitat Levalle O, Zylbersztein C, Aszpis S, Aquilano D, Terradas C, Colombani M, Aranda C, Scaglia H (1998) Recombinant human follicle-stimulating hormone administration increases testosterone production in men, possibly by a Sertoli cell-secreted nonsteroid factor. J Clin Endocrinol Metab 83(11):3973–3976PubMed Levalle O, Zylbersztein C, Aszpis S, Aquilano D, Terradas C, Colombani M, Aranda C, Scaglia H (1998) Recombinant human follicle-stimulating hormone administration increases testosterone production in men, possibly by a Sertoli cell-secreted nonsteroid factor. J Clin Endocrinol Metab 83(11):3973–3976PubMed
11.
Zurück zum Zitat Lloyd FH, Powell P Murdoch AP (1996) Anabolic steroid abuse by bodybuilders and male subfertility. Br Med J 313:100–101 Lloyd FH, Powell P Murdoch AP (1996) Anabolic steroid abuse by bodybuilders and male subfertility. Br Med J 313:100–101
12.
Zurück zum Zitat McLachlan RI, O’Donnell L, Meachem SJ, Stanton PG, de K, Pratis K, Robertson DM (2002) Hormonal regulation of spermatogenesis in primates and man: insights for development of the male hormonal contraceptive. J Androl 23(2):149–162PubMed McLachlan RI, O’Donnell L, Meachem SJ, Stanton PG, de K, Pratis K, Robertson DM (2002) Hormonal regulation of spermatogenesis in primates and man: insights for development of the male hormonal contraceptive. J Androl 23(2):149–162PubMed
13.
Zurück zum Zitat Meistrich ML, Shetty G (2003) Suppression of testosterone stimulates recovery of spermatogenesis after cancer treatment. Int J Androl 26(3):141–146CrossRefPubMed Meistrich ML, Shetty G (2003) Suppression of testosterone stimulates recovery of spermatogenesis after cancer treatment. Int J Androl 26(3):141–146CrossRefPubMed
14.
Zurück zum Zitat Nieschlag E, Behre HM (eds) (1997) Andrology: male reproductive health and dysfunction. Springer, Berlin, Heidelberg, New York Nieschlag E, Behre HM (eds) (1997) Andrology: male reproductive health and dysfunction. Springer, Berlin, Heidelberg, New York
15.
Zurück zum Zitat Ochsenkuhn R, De Kretser DM (2003) The contributions of deficient androgen action in spermatogenic disorders. Int J Androl 26(4):195–201CrossRefPubMed Ochsenkuhn R, De Kretser DM (2003) The contributions of deficient androgen action in spermatogenic disorders. Int J Androl 26(4):195–201CrossRefPubMed
16.
Zurück zum Zitat O’Donnell L, Robertson KM, Jones ME, Simpson ER (2001) Estrogen and spermatogenesis. Endocr Rev 22(3):289–318PubMed O’Donnell L, Robertson KM, Jones ME, Simpson ER (2001) Estrogen and spermatogenesis. Endocr Rev 22(3):289–318PubMed
17.
Zurück zum Zitat Paniagua R, Nistal M, Saez FJ, Fraile B (1991) Ultrastructure of the aging human testis. J Electron Microsc Tech 19(2):241–260PubMed Paniagua R, Nistal M, Saez FJ, Fraile B (1991) Ultrastructure of the aging human testis. J Electron Microsc Tech 19(2):241–260PubMed
18.
Zurück zum Zitat Parker KL, Schimmer BP, Schedl A (1999) Genes essential for early events in gonadal development. Cell Mol Life Sci 55:831–838PubMed Parker KL, Schimmer BP, Schedl A (1999) Genes essential for early events in gonadal development. Cell Mol Life Sci 55:831–838PubMed
19.
Zurück zum Zitat Pierik FH, Van Ginneken AM, Dohle GR, Vreeburg JT, Weber RF (2002) The advantages of standardized evaluation of male infertility. Int J Androl 23(6):340–346CrossRef Pierik FH, Van Ginneken AM, Dohle GR, Vreeburg JT, Weber RF (2002) The advantages of standardized evaluation of male infertility. Int J Androl 23(6):340–346CrossRef
20.
Zurück zum Zitat Sharpe RM, Kerr JB, McKinnell C, Millar M (1994) Temporal relationship between androgen-dependent changes in the volume of seminiferous tubule fluid, lumen size and seminiferous tubule protein secretion in rats. J Reprod Fertil 101(1):193–198PubMed Sharpe RM, Kerr JB, McKinnell C, Millar M (1994) Temporal relationship between androgen-dependent changes in the volume of seminiferous tubule fluid, lumen size and seminiferous tubule protein secretion in rats. J Reprod Fertil 101(1):193–198PubMed
21.
Zurück zum Zitat Singh J, O’Neill C, Handelsman DJ (1995) Induction of spermatogenesis by androgens in gonadotropin-deficient (hpg) mice. Endocrinology 136(12):5311–5321PubMed Singh J, O’Neill C, Handelsman DJ (1995) Induction of spermatogenesis by androgens in gonadotropin-deficient (hpg) mice. Endocrinology 136(12):5311–5321PubMed
22.
Zurück zum Zitat Sun YT, Irby DC, Robertson DM, de Kretser DM (1989) The effects of exogenously administered testosterone on spermatogenesis in intact and hypophysectomized rats. Endocrinology 125(2):1000–1010PubMed Sun YT, Irby DC, Robertson DM, de Kretser DM (1989) The effects of exogenously administered testosterone on spermatogenesis in intact and hypophysectomized rats. Endocrinology 125(2):1000–1010PubMed
23.
Zurück zum Zitat Turek PJ, Williamsl RH, Gilbaugh JH, Lipshultz LI (1995) The reversibility of anabolic steroid-induced azoospermia. J Urol 153(5):1628–1630PubMed Turek PJ, Williamsl RH, Gilbaugh JH, Lipshultz LI (1995) The reversibility of anabolic steroid-induced azoospermia. J Urol 153(5):1628–1630PubMed
24.
Zurück zum Zitat Vandekerckhove P, Lilford R, Vail A, Hughes E (2000) Androgens versus placebo or no treatment for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev 2:CD000150PubMed Vandekerckhove P, Lilford R, Vail A, Hughes E (2000) Androgens versus placebo or no treatment for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev 2:CD000150PubMed
25.
Zurück zum Zitat van Roijen JH, Ooms MP, Weber RF, Brinkmann AO, Grootegoed JA, Vreeburg JT (1997) Comparison of the response of rat testis and accessory sex organs to treatment with testosterone and the synthetic androgen methyltrienolone (R1881). J Androl 18(1):51–61PubMed van Roijen JH, Ooms MP, Weber RF, Brinkmann AO, Grootegoed JA, Vreeburg JT (1997) Comparison of the response of rat testis and accessory sex organs to treatment with testosterone and the synthetic androgen methyltrienolone (R1881). J Androl 18(1):51–61PubMed
26.
Zurück zum Zitat Vreeburg JT (1975) Distribution of testosterone and 5alpha-dihydrotestosterone in rat epididymis and their concentrations in efferent duct fluid. J Endocrinol 67(2):203–210PubMed Vreeburg JT (1975) Distribution of testosterone and 5alpha-dihydrotestosterone in rat epididymis and their concentrations in efferent duct fluid. J Endocrinol 67(2):203–210PubMed
27.
Zurück zum Zitat Walsh PC, Madden JD, Harrod MJ, Goldstein JL, MacDonald PC, Wilson JD (1974) Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Engl J Med 291(18):944–949PubMed Walsh PC, Madden JD, Harrod MJ, Goldstein JL, MacDonald PC, Wilson JD (1974) Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Engl J Med 291(18):944–949PubMed
28.
Zurück zum Zitat Weinbauer GF, Nieschlag E (1993) Gonadotrophin-releasing hormone analogue-induced manipulation of testicular function in the monkey. Hum Reprod 8[Suppl 2]: 45–50 Weinbauer GF, Nieschlag E (1993) Gonadotrophin-releasing hormone analogue-induced manipulation of testicular function in the monkey. Hum Reprod 8[Suppl 2]: 45–50
29.
Zurück zum Zitat Zitmann M, Nieschlag E (2003) The CAG repeat polymorphism within the androgen receptor gene and maleness. Int J Androl 26(2):76–83PubMed Zitmann M, Nieschlag E (2003) The CAG repeat polymorphism within the androgen receptor gene and maleness. Int J Androl 26(2):76–83PubMed
Metadaten
Titel
Androgens and male fertility
verfasst von
G. R. Dohle
M. Smit
R. F. A. Weber
Publikationsdatum
01.11.2003
Verlag
Springer-Verlag
Erschienen in
World Journal of Urology / Ausgabe 5/2003
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-003-0365-9

Weitere Artikel der Ausgabe 5/2003

World Journal of Urology 5/2003 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.